This is a real-world multicentre study to investigate the association between blood routine parameters combined with clinicopathological characteristics and breast cancer prognosis.
Study Type
OBSERVATIONAL
Enrollment
2,946
blood routine test at baseline
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, China
Disease-free survival
Disease-free survival time is defined as the time from the date of radical surgery until the date of the first occurrence of local/regional relapse, distant recurrence, contralateral breast cancer, second malignancy and death from any cause.
Time frame: From the date of radical surgery until time of event up to 3 years
Recurrence-free survival
Recurrence-free survival time is defined as the time from the date of radical surgery until the date of the first occurrence of local/regional recurrence, distant recurrence and death from any cause
Time frame: From the date of radical surgery until time of event up to 3 years
Overall survival
Overall survival time is defined as the time from the date of radical surgery until death from any cause until death from any cause
Time frame: From the date of radical surgery until time of event up to 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.